Medtronic stock: Medtronic reports on November 17, 2026. Medtronic stock yields 3.00 percent
Published on 10/16/2026 at 16:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDates and valuation guide
- Medtronic is scheduled to report on November 17, 2026.
- Its price-to-earnings ratio is 23.48 on October 16, 2026.
- Medtronic stock costs EUR 84.71 at Lang & Schwarz on October 16, 2026 at 4:38 p.m. CEST, 0.90 percent below the Xetra close of October 15, 2026.
- Medtronic's market capitalization is USD 122.0 billion as of October 16, 2026.
Medtronic is scheduled to report its next results on November 17, 2026, according to Gekko. The date gives investors a defined checkpoint after a volatile stretch for the medical-device maker. Medtronic was trading at EUR 84.71 at Lang & Schwarz on October 16, 2026 at 4:38 p.m. CEST, minus 0.90 percent versus the Xetra close of October 15, 2026 at EUR 85.48.
Valuation sets the next test
Medtronic's price-to-earnings ratio was 23.48 on October 16, 2026, while its dividend yield stood at 3.00 percent. The combination places the scheduled results date alongside two valuation measures that investors can track without relying on the daily euro quotation alone.
On the NYSE, Medtronic was last at USD 95.38 on October 16, 2026 at 10:49 a.m. ET. Its 52-week range was USD 73.31 to USD 106.33 on the same date, leaving the home-market price 10.29 percent below the high and 30.10 percent above the low.
Price position and trading range
The Lang & Schwarz quote stood below the Xetra close by EUR 0.77. The primary-market quote was down 0.08 percent from its previous close of USD 95.45 at the recorded time, while the German euro quotation remained within the broader 52-week picture translated through the separate home-market figures.
Market value and peers
Medtronic's market capitalization was USD 122.0 billion as of October 16, 2026. The company is listed on the NYSE under ticker MDT, as 6ix identifies it.
Comparison with peers
Medtronic plc (NYSE, USD): minus 0.90 percent, P/E 23.48, market capitalization USD 122.0 billion
Abbott Laboratories (NYSE, USD): plus 0.24 percent, P/E 33.73, market capitalization USD 181.6 billion
Boston Scientific (NYSE, USD): plus 0.26 percent, P/E 17.99, market capitalization USD 64.1 billion
What the November date brings
The November 17 reporting date is the next scheduled corporate checkpoint named in the reviewed market calendar. For investors, the key comparison will be whether the next period supports the valuation already reflected in a 23.48 price-to-earnings ratio and a 3.00 percent dividend yield.
Stock snapshot in euros
Medtronic's euro quotation was EUR 84.71 at Lang & Schwarz on October 16, 2026 at 4:38 p.m. CEST, down 0.90 percent from the Xetra close of October 15, 2026 at EUR 85.48.
The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.
Medtronic plc market data
- Company: Medtronic plc
- ISIN: IE00BTN1Y115
- Ticker: MDT
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 16, 2026, 4:38 p.m. CEST): EUR 84.71
- Change versus Xetra close: minus 0.90 percent
- Xetra close (October 15, 2026): EUR 85.48
- Market capitalization: USD 122.0 billion (as of October 16, 2026)
- 52-week range: USD 73.31-106.33 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical devices
- Next earnings date: November 17, 2026
Market context: Market report S&P 500.
